MIMA provides a 3‑D microwave imaging system that creates volumetric breast scans using low‑power, non‑ionizing electromagnetic waves, eliminating compression and radiation. The platform includes radar‑based reconstruction and AI‑driven ROI detection with quantitative malignancy scores, exporting DICOM‑compatible images and reports for integration into hospital PACS/RIS. It is designed for breast imaging departments and mobile screening programs serving high‑risk, dense‑breasted patients.
Funding
Funding not disclosed
Founders
Product
Problem
Mammography’s 2‑D X‑ray approach provides limited sensitivity in dense breast tissue, missing up to 40 % of cancers and leading to delayed diagnoses, especially in women under 50. The need for supplemental, radiation‑free screening methods for high‑risk, dense‑breasted populations remains unmet.
Solution
MIMA offers a 3‑D microwave imaging platform that captures volumetric breast images using low‑power electromagnetic waves at microwave frequencies, comparable to those in mobile phones. The system operates without breast compression and eliminates ionizing radiation, improving patient comfort and safety. Integrated radar‑based reconstruction algorithms generate high‑resolution volumetric datasets that are automatically analyzed to identify suspicious regions of interest. Proprietary software assigns malignancy scores to each ROI, delivering standardized reports that can be reviewed by clinicians. A fixed scan protocol enables trained technologists to perform examinations without requiring a radiologist on‑site, facilitating scalable deployment in busy imaging centers.
Target Audience
Primary customers are breast imaging departments in hospitals, diagnostic radiology clinics, and mobile screening programs that serve high‑risk women with dense breasts and seek a radiation‑free supplemental modality.
Features
- Low‑power microwave radar transmitter and receiver array for non‑ionizing, compression‑free 3‑D breast imaging
- Real‑time volumetric reconstruction pipeline delivering isotropic resolution suitable for dense tissue assessment
- Automated ROI detection using signal‑processing and machine‑learning classifiers to highlight potential lesions
- Quantitative malignancy scoring algorithm that computes tissue dielectric properties and morphological metrics
- Standardized scan workflow executable by certified technologists, reducing operator dependence
- Secure DICOM‑compatible export of volumetric images and structured reports for integration with PACS/RIS systems
- Compliance with medical device safety standards (e.g., IEC 60601‑2‑33) and HIPAA‑grade data handling